Athletic Lung Performance Protocol

Integrative, physician-designed protocol to enhance lung capacity, breathing efficiency, and aerobic performance — combining ALIV’s NAD+ IV therapy and PRP for Lungs with structured breathwork and performance nutrition. For athletes, endurance competitors, and high-performers.

At a Glance

What it targets: Lung capacity, breathing efficiency, oxygen utilisation, mitochondrial energy, alveolar and bronchial tissue health, recovery rate between training sessions.

Who it’s for: Swimmers, marathon runners, HYROX competitors, triathletes, cyclists, ultra-runners, and recreational athletes wanting more aerobic capacity. Healthy adults. For diagnosed lung disease, see ALIV’s Lung Rejuvenation Protocol.

How it works: ALIV’s two core clinic-administered interventions — NAD+ IV therapy (cellular energy and recovery) and PRP for Lungs (regenerative growth-factor delivery to lung tissue) — combined with structured breathwork, performance nutrition, and bloodwork-driven repletion.

What to expect: Measurable changes in lung function (MIP, MEP, vital capacity), breath economy, and recovery rate over 8-12 weeks. Performance gains in events typically follow.

Who This Protocol Is For

Indian endurance and high-performance athletics is growing rapidly. Many of our athletes arrive researching how to increase lung capacity, NAD+ IV for athletes, PRP for lungs, lung capacity training, VO2max improvement, or breathing exercises for athletes in India — looking for an evidence-based, physician-supervised approach.

This protocol is for healthy athletes seeking enhancement — not clients with diagnosed lung disease. For COPD, pulmonary fibrosis, post-COVID damage, or other respiratory conditions, the Lung Rejuvenation Protocol is the correct pathway.

This protocol was built for you if:

• You compete in or train for swimming, marathon, ultra-running, HYROX, triathlon, cycling, or other endurance sport and want measurable lung capacity gains
• You’re a recreational athlete targeting personal bests and have hit a plateau on breath capacity or recovery between efforts
• You’re preparing for a specific event and want a structured 8-16 week protocol
• You’re a healthy adult above 35 noticing aerobic capacity declining and want to defend it
• You want a physician-supervised, regenerative approach to lung performance — not unverified peptide protocols or shortcuts

How It Works — The ALIV Approach

The lung is trainable, but training alone has limits. The ALIV approach goes further by adding two clinic-administered interventions designed to enhance lung tissue capacity at the cellular level — NAD+ IV therapy and PRP for Lungs — alongside structured breathwork, performance nutrition, and bloodwork-driven repletion. 5 individualised layers; not every athlete needs every layer.

Layer 1 — Pulmonary Function Baseline & Phenotyping

Standard spirometry plus MIP, MEP, vital capacity, and breath-hold tolerance. Athletes bring VO2max data from existing devices (Garmin, Apple Watch, Polar, Whoop, Coros) — accepted as baseline. Re-testing at 8-12 weeks tracks progress.

Inspiratory Muscle Training (IMT) — at-home practice, not a clinic service: Daily IMT with PowerBreathe or threshold trainer (athlete-purchased) — 30 breaths twice daily against 50-70% MIP resistance, progressively increased. RCTs in swimmers, runners, cyclists show 8-12% MIP improvement over 6-12 weeks. Complements the clinic-administered layers below.

Layer 2 — Breathwork & Diaphragmatic Mastery

Three core practices, 15-20 minutes daily: diaphragmatic breathing (many adults breathe only with chest muscles), box breathing (CO2 tolerance and autonomic regulation), and nadi shodhana (parasympathetic activation, widely used by Indian endurance athletes). Cost nothing; measurable improvements in breath economy.

Layer 3 — NAD+ IV Therapy: Core Cellular Energy Intervention

NAD+ (nicotinamide adenine dinucleotide) is the central coenzyme of mitochondrial energy metabolism — required for oxidative phosphorylation, sirtuin activation, DNA repair, and cellular adaptation to training load. Pulmonary epithelial cells, type II pneumocytes, and respiratory muscle fibres depend on robust NAD+ status, and levels decline with age and intense training. ALIV’s NAD+ IV protocol delivers therapeutic doses directly, bypassing first-pass metabolism. In athletic context: faster mitochondrial recovery, improved fatigue resistance, enhanced cellular repair, stronger training-adaptation signalling.

WADA note: NAD+ is an endogenous coenzyme and not itself prohibited. However, standard IV volumes exceed WADA Method M2.2 (100mL/12h) for tested athletes. ALIV offers compliant alternatives — sublingual NAD+, oral NMN/NR precursors, or smaller-volume IV protocols. Recreational athletes not subject to WADA testing receive the standard IV protocol.

Layer 4 — PRP for Lungs: Core ALIV Specialty Intervention

ALIV’s PRP for Lungs is the second core intervention. Autologous platelet-rich plasma — from the athlete’s own blood — is delivered via nebulisation so growth factors (PDGF, VEGF, TGF-β, EGF, IGF-1) reach alveolar and bronchial tissue. These support epithelial repair, capillary density, and alveolar tissue homeostasis — the substrate that determines lung capacity ceiling.

Evidence base: PRP is established in joint, tendon, and ovarian applications; lung PRP via nebulisation has pilot evidence in lung-disease populations. Healthy-athlete performance use is investigational with mechanism-driven rationale. WADA status: PRP removed from prohibited list 2011; autologous origin minimises contamination concerns.

Layer 5 — Performance Nutrition & Targeted Repletion

Bloodwork-driven, not blanket supplementation. Threshold targets at workup: serum ferritin (below 30 ng/mL indicates iron deficiency that silently caps performance even before haemoglobin drops), full anaemia screen (haemoglobin, ferritin, B12, folate, transferrin saturation — corrected before training intensification), and ceramides (emerging cardiometabolic marker; elevated levels correlate with endothelial dysfunction and reduced exercise capacity).

Targeted supplementation: niacin and niacinamide (oral NAD+ precursors complementing the IV protocol), beetroot / dietary nitrate (~3-5% endurance improvement in trials), CoQ10 / Ubiquinol (mitochondrial energetics), omega-3 (EPA/DHA) (anti-inflammatory, cardiovascular adaptation), magnesium (bronchodilation, muscle function), vitamin D (respiratory immunity — deficient in many Indian adults), iron (where ferritin indicates), NAC, beta-alanine, citrulline malate added sport- and intensity-specifically.

What to Expect

Most athletes see MIP and breath-economy changes within 6-8 weeks. NAD+ IV effects on energy and recovery are typically noticed within 1-3 sessions; cumulative adaptation builds over months. PRP for Lungs is investigational; changes tracked via spirometry and VO2max. Adherence to breathwork, IMT, and lifestyle is the dominant variable.

Outcomes vary based on baseline, sport, training age, adherence, and genetic factors. ALIV does not guarantee specific performance gains, race times, or competitive outcomes.

What’s Involved

Before starting, your ALIV team runs the Layer 1 diagnostic, the Layer 5 bloodwork, and reviews your sport, training calendar, and goals. Coach coordination offered. Contraindications detailed below.

The Lifestyle Layer — Foundational

Performance protocols don’t replace training fundamentals — they amplify them.

Movement: periodised Zone 2 base, VO2max intervals, sport-specific work, structured strength. Nutrition: adequate protein, carb periodisation, micronutrient sufficiency. Sleep: 7-9 hours. Stress: breathwork doubles as stress protocol. Environment: avoid high-pollution training days (PM2.5 acutely reduces lung function for hours).

Frequently Asked Questions

How is this different from the Lung Rejuvenation Protocol?

Different audiences. Lung Rejuvenation is for clients with diagnosed or developing lung disease — COPD, pulmonary fibrosis, post-COVID damage, post-TB scarring, pollution-driven dysfunction. Athletic Lung Performance is for healthy athletes seeking enhancement.

What does NAD+ IV actually do for athletic lung performance?

NAD+ is central to mitochondrial energy. IV delivery rapidly raises cellular NAD+, supporting oxidative phosphorylation, sirtuin activation, DNA repair, and faster recovery between sessions — critical for high-output respiratory tissue function.

Is PRP for Lungs proven for athletic performance?

No — it’s investigational. PRP is established in joint, tendon, and ovarian use; lung PRP has pilot evidence in disease populations. Healthy-athlete enhancement use is mechanism-driven extrapolation. ALIV positions it honestly as an investigational adjunct.

Is this protocol WADA-compliant?

PRP is permitted. NAD+ substance is permitted, but standard IV volume exceeds WADA M2.2 (100mL/12h) for tested athletes — ALIV offers compliant alternatives (sublingual, oral NMN/NR, smaller IV). Most recreational athletes are not WADA-tested and receive the standard protocol.

How long until I see improvements?

NAD+ energy and recovery changes within 1-3 sessions. MIP and breath-economy gains in 6-8 weeks. Event performance typically over 8-16 weeks.

Can lung capacity be increased after a certain age?

Yes. Inspiratory muscle strength, breath economy, mitochondrial function, and tissue health remain modifiable into later decades. Masters athletes show documented gains.

Who should NOT do this protocol?

Active acute respiratory illness; uncontrolled cardiovascular disease; severe asthma or diagnosed lung disease (route to Lung Rejuvenation Protocol instead); pregnancy without obstetric clearance; bleeding disorders or anticoagulant therapy (PRP contraindications).

Take the Next Step

Athletic lung performance is built at the cellular level, not just at the training level. The ALIV protocol combines NAD+ IV, PRP for Lungs, breathwork, and bloodwork-driven nutrition into a structured, physician-supervised programme.

To find out if the Athletic Lung Performance Protocol is right for you, speak with our medical team:

• Pune (Bund Garden): +91 77199 88811
• Mumbai (Khar West): +91 98220 93069

Or book a consultation through alivtherapy.in.

Research References

1. HajGhanbari B, Yamabayashi C, Buna TR, et al. Effects of respiratory muscle training on performance in athletes: a systematic review with meta-analyses. J Strength Cond Res. 2013;27(6):1643-1663. PMID: 22836606

2. Jones AM, Thompson C, Wylie LJ, Vanhatalo A. Dietary nitrate and physical performance. Annu Rev Nutr. 2018;38:303-328. PMID: 30130468

3. Rajman L, Chwalek K, Sinclair DA. Therapeutic potential of NAD-boosting molecules: the in vivo evidence. Cell Metab. 2018;27(3):529-547. PMID: 29514064

4. DellaValle DM. Iron supplementation for female athletes: effects on iron status and performance outcomes. Curr Sports Med Rep. 2013;12(4):234-239. PMID: 23851410

5. World Anti-Doping Agency. The 2026 Prohibited List — International Standard. WADA, effective January 1, 2026.

Disclaimer

The information on this page is for educational purposes only and is not intended as medical advice. ALIV therapies are not intended to diagnose, treat, cure, or prevent any disease. PRP for Lungs is positioned honestly as an investigational adjunct with mechanism-driven rationale, not as proven athletic enhancement. Athletic performance outcomes vary substantially based on genetic factors, training history, adherence, and sport-specific demands. ALIV does not guarantee specific performance gains, competitive outcomes, or race times. Athletes subject to drug testing are responsible for verifying compliance with their sport governing body in addition to WADA, and should discuss NAD+ IV volume and any other intervention with ALIV before starting.